Valo Therapeutics Oy
2768695-4ActiveDeveloping novel peptide-coated oncolytic virus immunotherapies for cancer.
Overview
- Unknown
- Employees
- Unknown
- Revenue
- 2016
- Founded
Key Decision Makers
Marcella Origgi
Chief Executive Officer
Matti Hautsalo
Member of the Board
Lukasz Kuryk
Chief Development Officer
Andrew Dean
Member of the Board
+23 more contacts in Funnelfeedr
Description
Valo Therapeutics (ValoTx) is a biotechnology company spun out from the University of Helsinki, specializing in cancer immunotherapy. The organization focuses on developing novel treatments by uniquely combining oncolytic virus therapy, peptide vaccination, and viral vector approaches. Their core pr...
Tags
Keywords
Tech Stack
Company Information
- Industry
- Unknown
- Legal Form
- 16
- VAT Number
- FI27686954
Decision Makers
27 contacts in FunnelfeedrMarcella Origgi
Chief Executive Officer
Matti Hautsalo
Member of the Board
Lukasz Kuryk
Chief Development Officer
Andrew Dean
Member of the Board
Jeffrey Bockman
Member of the Scientific and Clinical Advisory Board
Harri Jarvelainen
Chief Operating Officer
Otto Kari
VP, Head of Antigen Business Unit
Vincenzo Cerullo
Scientific Founder and Scientific Advisor
Kevin Harrington
Member of the Scientific and Clinical Advisory Board
David Hinton
Chair of the Board
Hanne Cojoc
Head of Quality and Operations
Leena Ylösmäki
VP Preclinical Development
Eleonora Leggiero
Head of CMC and Italian Operations
Sari Pesonen
Chief Scientific Officer
Austin Smith
Medical Director
Petri Priha
VP of CMC
Charlotta Backman
VP of Clinical Operations and Regulatory Affairs
Paul Porter
Member of the Board
Malcolm K. Brenner
Member of the Scientific and Clinical Advisory Board
Paolo Antonio Ascierto
Member of the Scientific and Clinical Advisory Board
Other Contacts
Joseph Ndika
Senior Scientist, Antigen Analytics
Suvi Karumo
Laboratory Scientist, Antigen Business Unit
Philip Stanecki
Financial Controller
Matthew Vaughan
Communications Contact
+3 more contacts in Funnelfeedr
Similar Companies
20 similar companies in FunnelfeedrSolid Immuno-Oncology Oy
Developing organ-on-chip technology for advanced cancer treatment decisions.
Sox Therapeutics AB
1 employeesDeveloping targeted AAV gene therapies for malignant brain tumors.
AAX Biotech AB
5–9 employeesResearch-driven biotech advancing antibody therapies via proprietary technology.
Nanohumps Biosciences Oy
Pioneering revolutionary cancer therapies using proprietary nanosized antibodies.
Oncotech Nordic AB
0 employeesDeveloping AI diagnostics and immunotherapy to conquer global cancer.
Browse More
Valo Therapeutics Oy Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo